Stephen Doster
-
Senior Associate Dean of Basic Sciences Roger Chalkley to Retire
Lorena Infante Lara Roger Chalkley, professor of molecular physiology and biophysics and senior associate dean for biomedical research education and training, will be retiring this summer. Chalkley, who has been at Vanderbilt since 1986, is also a co-PI of the Initiative for Maximizing Student… Read MoreApr. 23, 2021
-
3 QUESTIONS ON… How Tumor Cells Grow With Maria Fomicheva of Vanderbilt University
Maria Fomicheva (Kaverina lab) is featured in the April 20, 2021 issue of Oncology Times. CRISPR (which stands for “clustered regularly interspaced short palindromic repeats”) is a genome screening tool that allows researchers to edit or delete individual genes—as well as identify the specific genes in the body responsible… Read MoreApr. 22, 2021
-
Steve Townsend wins David Y. Gin Young Investigator Award
by Marissa Shapiro Apr. 16, 2021, 9:00 AM By Miquéla Thornton Steven Townsend (Vanderbilt University) Assistant Professor of Chemistry Steven D. Townsend has been awarded the 2021 David Y. Gin Young Investigator Award by the American Chemical Society. The award is one… Read MoreApr. 16, 2021
-
New insights into kidney development
Apr. 15, 2021, 9:30 AM by Bill Snyder Integrins serve as adhesion receptors for proteins in the extracellular matrix and transduce biochemical signals into the cell. They regulate cell functions including migration, proliferation and apoptosis (programmed cell death). The ILK-PINCH-parvin protein complex (IPP) functions as an intracellular signaling platform for integrins… Read MoreApr. 15, 2021
-
Arrhythmia culprit: supertrafficking ion channel
Apr. 15, 2021, 9:00 AM by Leigh MacMillan The potassium channel KCNQ1 plays a critical role in the cardiac action potential — the electrical activity underlying heart muscle contraction. Inherited mutations resulting in loss of channel function or gain of function (GOF) cause heart rhythm abnormalities. Charles Sanders,… Read MoreApr. 15, 2021
-
Vanderbilt research: Better understanding of fundamental cell behavior can improve drug development
by Marissa Shapiro Apr. 13, 2021, 9:00 AM Pioneering research from Vanderbilt scientists shows that cells respond differently to acute stress than to gradual stress. The findings establish an entirely new way to look at cell-to-cell communication, or signaling, and may fundamentally change how… Read MoreApr. 15, 2021
-
Class of 2021: Interdisciplinary teamwork in the lab leads Ph.D. student to job with biotech giant
Apr. 9, 2021, 8:00 AM Alissa Guarnaccia, Ph.D. in cell and developmental biology, School of Medicine Basic Sciences (Vanderbilt University) Alissa Guarnaccia is jumping into a highly sought-after research career to help find treatments for cancer at the cellular level. But lately she’s taking time to write lots of thank-you… Read MoreApr. 13, 2021
-
Personalized Structural Biology aids cancer treatment decisions
Apr. 8, 2021, 8:55 AM by Bill Snyder Cancer specialists at Vanderbilt University Medical Center, in partnership with biochemists and structural biologists across the Vanderbilt University campus, are taking “personalized” cancer therapy to a new level. Benjamin Brown, left, Jens Meiler, PhD, Zhenfang Du, PhD, and colleagues are studying the… Read MoreApr. 9, 2021
-
Dr. James Crowe Jr. receives SEC Faculty Achievement Award
by Ann Marie Deer Owens Apr. 8, 2021, 1:30 PM Dr. James Crowe Jr., professor of medicine, in his lab at Medical Research Building IV. (John Russell/Vanderbilt University) Dr. James E. Crowe Jr., a physician-scientist on the front lines of global research… Read MoreApr. 9, 2021
-
Study revises understanding of cancer metabolism
Apr. 7, 2021, 10:00 AM From left, Kimryn Rathmell, MD, PhD, Bradley Reinfeld, Matthew Madden and Jeffrey Rathmell, PhD, have discovered that immune cells — not cancer cells — are the major glucose consumers in the tumor microenvironment, upending a century-old observation. (photo by Susan Urmy) by Leigh MacMillan Tumors… Read MoreApr. 9, 2021